![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Second-generation hepatitis B virus core inhibitors ABI-H2158 and ABI-H3733
have enhanced potency and target coverage for both antiviral inhibition and covalently closed circular DNA establishment activities
|
|
|
EASL International Liver Congress, June 23-26, 2021 JNJ-3989
Dawei Cai, Marc Evanchik, Ran Yan, Renuka Kumar, Yuhua Zong, Qi Huang, Richard Colonno, Kathryn Kitrinos, Luisa M Stamm, William Delaney
Assembly Biosciences, Inc., South San Francisco, CA, USA
![0628211](../images/082521/062821-3/0628211.gif)
![0628212](../images/082521/062821-3/0628212.gif)
![0628213](../images/082521/062821-3/0628213.gif)
![0628214](../images/082521/062821-3/0628214.gif)
![0628215](../images/082521/062821-3/0628215.gif)
![0628216](../images/082521/062821-3/0628216.gif)
![0628217](../images/082521/062821-3/0628217.gif)
![0628218](../images/082521/062821-3/0628218.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|